1. Leukemia. 2018 Aug;32(8):1842-1845. doi: 10.1038/s41375-018-0145-6. Epub 2018 
Apr 24.

JAK/MAP kinase pathway activation and TP53 mutations in acute leukemia with 
megakaryocytic and erythroid differentiation.

Xiao W(1), Rampal R(2), Zhang Y(3), Cimera R(3), Jungbluth AA(4), Arcila M(5), 
Roshal M(4), Park DC(4)(6).

Author information:
(1)Hematopathology Diagnostic Service, Department of Pathology, Memorial Sloan 
Kettering Cancer Center, New York, NY, USA. xiaow@mskcc.org.
(2)Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer 
Center, New York, NY, USA.
(3)Cytogenetic Laboratory, Department of Pathology, Memorial Sloan Kettering 
Cancer Center, New York, NY, USA.
(4)Hematopathology Diagnostic Service, Department of Pathology, Memorial Sloan 
Kettering Cancer Center, New York, NY, USA.
(5)Diagnostic Molecular Laboratory, Department of Pathology, Memorial Sloan 
Kettering Cancer Center, New York, NY, USA.
(6)Department of Pathology, Columbia University Medical Center, New York, NY, 
USA.

DOI: 10.1038/s41375-018-0145-6
PMCID: PMC7472720
PMID: 29743724 [Indexed for MEDLINE]

Conflict of interest statement: Conflict-of-interest disclosure: The authors 
declare no competing financial interests.